Mark Levis discusses the novelties in acute myeloid leukemia at the American Society of Hematology's 67th Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:novelties-acute-myeloid-leukemia-ash2025

Michael J. Mauro discusses the state of the art treatment of chronic myeloid leukemia at the American Society of Hematology's 67th Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-chronic-myeloid-leukemia

Mikkael A. Sekeres discusses the state of the art treatment in myelodysplastic syndrome at the American Society of Hematology's 67th Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:myelodysplastic-syndrome-highlights-ash-2025

Andrzej Jakubowiak discusses the COBRA trial and other novelties in multiple myeloma at the American Society of Hematology's 67th Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:cobra-trial-and-other-novelties-multiple-myeloma-ash-2025

Paul G Richardson discusses multiple myeloma highlights at the American Society of Hematology's 67th Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:multiple-myeloma-highlights-ash-2025

Sigbjorn Berentsen discusses the diagnosis and management of cold agglutinin disease at the American Society of Hematology's 67th Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:diagnosis-and-management-cold-agglutinin-disease

Xavier Leleu explains the breakthrough in the treatement of multiple myeloma at the American Society of Hematology's 67th Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:breakthrough-treatement-multiple-myeloma

Joshua Brody discusses the novelties in diffuse large B-cell lymphoma at the American Society of Hematology's 67th Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:novelties-diffuse-large-b-cell-lymphoma-ash2025

Wojciech Jurczak discusses the results from the global, randomized BRUIN CLL-313 study presented at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:first-its-kind-phase-3-trial-shows-pirtobrutinib-noninferior-ibrutinib-treatment-naive-cll

Sabina Chiaretti discusses the results of the phase 3 GIMEMA ALL2820 study at the American Society of Hematology's 67th Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:new-findings-support-chemo-free-approach-treating-ph-all